Concepedia

Publication | Closed Access

Safety and immunogenicity of the α-synuclein active immunotherapeutic PD01A in patients with Parkinson's disease: a randomised, single-blinded, phase 1 trial

132

Citations

17

References

2020

Year

References

YearCitations

Page 1